Immune Response fka IMNR (IMNR)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

jculp

04/02/07 11:20 AM

Post #236

Anyone else following or holding this stock?

jculp

01/18/07 11:14 AM

Post #235

Anyone know why there is no volume today? Symbol change?

opmoney

12/21/06 8:12 AM

Post #234

Re: #233: @sdcraigo - WOW!!! What a wild ride today - from

My wonder is .... are they just playing the 3 days it takes for the shares to settle....or are things finally moving?

sdcraigo

12/20/06 6:03 PM

Post #233

Re: #232: @opmoney - so much for that money LOL

WOW!!! What a wild ride today - from a low of $0.74 to end at $2.10 for the day - up 183%.

opmoney

12/20/06 3:03 PM

Post #232

Re: #231: @jculp - Don't get too excited, they did a 100-1

so much for that money LOL

jculp

12/20/06 2:56 PM

Post #231

Re: #230: @opmoney - What happened? I dont see news or anything?

Don't get too excited, they did a 100-1 reverse split today, announced last week.

opmoney

12/20/06 2:09 PM

Post #230

Re: #228: @jculp - bye bye investment... oh well this was a

What happened? I dont see news or anything?

stocktalkpa Free

12/20/06 1:37 PM

Post #229

Re: #228: @jculp - bye bye investment... oh well this was a

I feel for you,,,,this has been the biggest dog on the block.....fun to watch and wish though.

jculp

12/20/06 10:46 AM

Post #228

bye bye investment... oh well this was a very long shot anyway.

mkinhaw

12/11/06 3:48 PM

Post #227

Re: #226: @Homer911 - because they said they plan to go into

This co has a looooooooooong
history of not making it
and they diluted a lot
you must read all the filings
most important will be if they r/s the a/s also
otherwise it will go down
and they must have some positive trial data
for their HIV drug
MK

Homer911

12/11/06 3:45 PM

Post #226

Re: #225: @mkinhaw - You will have 50 shares

because they said they plan to go into the major markets. They seem to have plans for growth.
whatdya think?

jmfo.

mkinhaw

12/11/06 3:42 PM

Post #225

Re: #224: @Homer911 - IMNR is going through a split? hmmm.

You will have 50 shares
will it go up ?
depends if they dilute anymore
MK

Homer911

12/11/06 3:39 PM

Post #224

Re: #222: @mkinhaw - IMNR 1 X 100 r/s Dec 20

IMNR is going through a split? hmmm.

so what does that mean if, say, I have 5000 shares?

why are they doing a split?

will pps go up after the split?

jculp

12/11/06 8:00 AM

Post #223

Just great... so this stock will tank until the 20th, reverse split and then tank again. Pretty much wiping out anyones holdings unless you got a few million shares.

mkinhaw

12/08/06 10:28 PM

Post #222

Re: #169: @shakerzzz - lets get this bird flyinggggggggggggggggggggg

IMNR 1 X 100 r/s Dec 20
new symbol IMNRD
MK

Homer911

11/30/06 12:16 AM

Post #221

Re: #217: @surf1944 - If you like the drug IMNR is working

'surf1944', Can you explain...

Homer911

11/29/06 7:37 PM

Post #220

BIG FUTURE.... i think.

how bout you?

Serfcorp

11/14/06 10:55 AM

Post #219

Re: #218: @jculp - getting some upward movement.. and volume.. maybe once

No follow through from yesterday,back to the waiting game *_*

jculp

10/20/06 9:54 AM

Post #218

getting some upward movement.. and volume.. maybe once the second block of stocks is done it will move over .02.

surf1944

10/06/06 7:28 PM

Post #217

If you like the drug IMNR is working on fine...just don't try and make money on the stock...billions are being printed...back burner this one...wait for a r/s say 1 for 100,000 & then let the new stock fall 99% then BUY that share...bottom line you can like what IMNR is working on ...just don't invest now.

GL

Stcgg

09/25/06 2:57 PM

Post #216

Bad Newz, Baggies...

IMNR on the Toxic Shock List of the DILUTION POLLUTION Kings, Cornell -

http://www.investorshub.com/boards/read_msg.asp?message_id=13545141

HoHoHo!

mediascan

09/12/06 8:11 AM

Post #215

Re: #214: @Stcgg - Move Caused by Too Much XLax, Needs Kaopectate.. Bwahajaa!!

CEOs of the American Stock Exchange, London Stock Exchange, Borsa Italiana to Kick Off EQUITIES Transatlantic Corporate Conference

2006-09-11 19:50 ET - News Release

Also News Release (U-AVMD) ADVANCED MEDICAL INSTITUTIONS
Also News Release (U-CGLD) CAPITAL GOLD CP
Also News Release (U-ISO) ISCO INTL INC

LOS ANGELES, CA -- (MARKET WIRE) -- 09/11/06

EQUITIES Magazine proudly announces its first-ever Transatlantic Corporate Conference, aimed at bringing together American small-cap companies and European investors. This exciting event will also be Webcast at http://www.visualwebcaster.com/equitiesmag/amex2006/event.html

An Investment Bridge To Europe:

EQUITIES Transatlantic Conference will begin on September 15 at the American Stock Exchange in New York City, where a select group of emerging growth companies will present to a sophisticated audience of brokers, fund managers, investment professionals and active retail investors. The keynote speaker for the event will be AMEX CEO Neal Wolkoff, followed by Senior VP of Equities John McGonegal. These promising public companies will then travel to the London Stock Exchange on the 18th, where they will be greeted by keynote speaker Martin Graham, Head of the AIM market. The conference will finish on the 20th at the Borsa Italiana stock exchange in Milan, with keynote speaker Lodovico Rosnati, Director of Equities Markets.

Presenting Companies

Of the 12 exciting companies presenting, four of these promising public companies are:

-- Advanced Medical Institute, Inc. (PINKSHEETS: AVMD) Las Vegas, NV --
operates a chain of medical clinics for the treatment of sexual dysfunction
in men and women, primarily in Australia. It provides medical services,
pharmaceuticals, and associated support services. The company offers
various treatment options, which include injections, lozenges, tablets, and
nasal delivery systems for the treatment of erectile dysfunction; and
injection, lozenges, and nasal spray delivery systems for the treatment of
premature ejaculation. As of September 30, 2005, it operated 17 clinics
and a centralized call center. Advanced Medical Institute is based in
Alexandria, Australia.

-- Capital Gold Corporation (OTCBB: CGLD) (TSX: CGC) New York City, NY --
engages in the exploration for gold and other minerals primarily in Mexico.
The company, through its wholly owned subsidiary, Oro de Altar S. de R. L.
de C.V. and its affiliate, Minera Santa Rita S. de R.L. de C.V., owns 16
mining concessions, known as El Chanate concessions, located in Altar,
Sonora, totaling approximately 3,544 hectares. It also has a lease on
surface property for mining the Chanate gold deposit, which consists of 466
hectares in Altar, Sonora. Further, the company owns or leases claims and
properties located in Lake County, Colorado.

-- The Immune Response Corp. (OTCBB: IMNR) Carlsbad, CA -- is developing
its lead immune-based therapeutic candidates: NeuroVax (TM) targeting
multiple sclerosis and IR103 for treatment of HIV infection. Both in Phase
II, designed to stimulate pathogen-specific immune responses to slow or
halt rate of disease progression. NeuroVax, based on IMNR's patented T-
cell receptor peptide technology, shows potential in treating relapsing
forms of MS. This patented whole-inactivated virus technology was co-
invented by Dr. Jonas Salk.

-- ISCO International (AMEX: ISO) Elk Grove Village, IL -- ISCO
International, Inc. is a leading global supplier of radio-frequency
management and interference-control systems for the wireless
telecommunications industry. By integrating state-of-the-art filtering,
duplexing and low noise amplifier technology, we improve the performance of
new and existing cellular deployments. ISCO products focus on software-
based, adaptive filtering solutions targeted at increasing the performance
of CDMA and WCDMA wireless systems worldwide.

Transatlantic Conference Sponsors include:

Marsten Webb International, an international corporate communications firm which offers an unrivaled knowledge of markets and media throughout the globe; Richardson & Patel, a fast-growing, bi-coastal business law firm dedicated to helping emerging growth companies get the legal expertise they need; Bankside, a London-based public relations consultancy firm with a detailed knowledge of overseas and dual listing; Bigdough, an innovative provider of capital markets contact and ownership data; Onstream Media Corporation, an online service provider of live and on-demand, rich media communications, specializing in online audio and video corporate communications; and Interbank FX, an online currency trading firm focused on providing direct access and the latest trading technology to its worldwide customers.

About EQUITIES Global Communications, Inc.

EQUITIES Magazine

EQUITIES Global Communications, Inc. is a privately held corporation based in Los Angeles, CA. EQUITIES Magazine is written in a no-holds-barred style developed by its award-winning editor Robert J. Flaherty -- a legend in financial journalism. Flaherty is considered one of the nation's most outstanding investigative reporters on undiscovered, emerging and middle-market companies, and was previously named "one of the most influential journalists" by The Journal of Financial Reporting. Covering the most exciting companies in the small and mid-cap markets, EQUITIES' readers include some of the financial community's most savvy and respected investment professionals -- including corporate executives, market makers, traders, fund managers, institutional investors, portfolio managers, stockbrokers, analysts and sophisticated individual investors. In addition, EQUITIES Magazine has developed the most comprehensive investor awareness programs on the market, developing strategic marketing campaigns to help expose promising public companies to the investor marketplace. Of these programs include our EQUITIES Corporate Conferences, currently held four times a year at the Yale Club in New York City. EQUITIES is also the publisher of the renowned stock advisory newsletter -- EQUITIES Special Situations, which gained 14.78% verses 6.2% for the Wilshire 5000 Index in 2005; making this the fourth year in a row that the newsletter has substantially beaten the Index, according to The Hulbert Financial Digest.

Stcgg

09/12/06 5:35 AM

Post #214

Re: #213: @heysutty - I think we are finally gonna start to move!

Move Caused by Too Much XLax, Needs Kaopectate.. Bwahajaa!!

heysutty

09/11/06 6:23 AM

Post #213

I think we are finally gonna start to move!

headnorthw Free

09/08/06 6:50 PM

Post #212

Re: #211: @ganador - Insiders buying here !

some volume surge in the last hour of trading. Is it a head fake again?

ganador

09/05/06 1:58 PM

Post #211

Insiders buying here !

Stcgg

09/04/06 10:39 AM

Post #210

Hi Again, Baggies!!

I see IMNR is still where she was last time I was here.. She's still going to $0.01 though, maybe even lower with the last round of DILUTION. Seeya there -- Bwhajaaa!

invest in kids Free

09/01/06 4:15 PM

Post #209

Director HOCHMAN has bought 6 million shares in the last few months.
That should tell you something.

ganador

08/30/06 10:53 AM

Post #208

0.02 !

headnorthw Free

08/28/06 11:04 PM

Post #207

Re: #206: @Stcgg - Hi Baggies, Still waiting on that X-Lax Relief? Bwhajaa!

Will this one get a good run? Hope we have a good PR so it can.

Stcgg

08/28/06 10:41 PM

Post #206

Hi Baggies, Still waiting on that X-Lax Relief? Bwhajaa!

headnorthw Free

08/25/06 7:16 PM

Post #205

Re: #204: @analitic - IMNR gapping

This stock needs volumes on the buy side. I thought it's ready to go up finally, but the volumes sucks.

analitic

08/25/06 9:29 AM

Post #204

Re: #203: @headnorthw - Are we finally at the start of an

IMNR gapping

headnorthw Free

08/24/06 8:12 PM

Post #203

Re: #202: @analitic - under 0.02 cheap !

Are we finally at the start of an expected run? It's due. GLTA!

analitic

08/24/06 7:17 PM

Post #202

under 0.02 cheap !

Stcgg

08/22/06 4:44 PM

Post #201

Re: #198: @ChangeDirector - Every make a daytrade stcgg? lol!

Ever Make a Daytrade? Today it was IGAI for Da Gappa..

Stcgg

08/22/06 4:43 PM

Post #200

Re: #199: @Ilbedem - nice bounce

Nice Bounce.. Right up to Old Support/New Resistance, HoHoHo!

Ilbedem

08/21/06 10:58 AM

Post #199

nice bounce

ChangeDirector Free

08/21/06 10:23 AM

Post #198

Re: #197: @Stcgg - Nay, They didn't sell yet......................

Every make a daytrade stcgg? lol!

Stcgg

08/18/06 9:20 PM

Post #197

Re: #196: @ChangeDirector - I think a lotta those baggies sold and

Nay, They didn't sell yet......................

The chart is going South just like I've been expecting once she put in New Lows. I'm expecting a repeat of the June action on this one, and where she stops nobody knows!

http://stockcharts.com/h-sc/ui

HoHoHo!!

ChangeDirector Free

08/18/06 9:13 PM

Post #196

Re: #195: @Stcgg - BWHAJAAAJAAAHAAAAAHAAAAHAAA!!!!! IMNR is a DILLUTED POS,, Poor Baggies..

I think a lotta those baggies sold and left the last coupla days. Me ... watching and waiting .... this stock is a fantastic daytrade.

Stcgg

08/18/06 9:02 PM

Post #195

BWHAJAAAJAAAHAAAAAHAAAAHAAA!!!!!

IMNR is a DILLUTED POS,, Poor Baggies..

headnorthw Free

08/18/06 8:52 PM

Post #194

Re: #193: @heysutty - what is going on with this stock down

This stock is being taking down hard today, for whatever reasons.

heysutty

08/18/06 5:00 PM

Post #193

what is going on with this stock down alot today but another big buy late in the day 2 days in a row?

ChangeDirector Free

08/18/06 4:46 PM

Post #192

Re: #191: @mkinhaw - Looking good

What the devil are you talking about MK?

mkinhaw

08/18/06 4:15 PM

Post #191

Looking good
pple must read filings
MK

Stcgg

08/17/06 8:45 AM

Post #190

Re: #189: @tecch10000 - Thanks for the buy tip Stcggp.o.s!Got .019 long!!

Cool!

http://www.investorshub.com/boards/read_msg.asp?message_id=12480188

But I wouldn't hold it any longer than it takes to sheer a few sheep (figuratively - Lol!), since the stock just put in NEW LOWS..

tecch10000 Free

08/16/06 2:36 PM

Post #189

Thanks for the buy tip Stcggp.o.s!Got .019 long!!
You're such a loveable little board turd.But thanks none the less for the awesome buy signal!!!Have GREAT DAY!!

Stcgg

08/16/06 9:48 AM

Post #188

$0.0189 Busted, No More Support Baggies..

HoHoHo!

Stcgg

08/16/06 9:46 AM

Post #187

$0.02 Busted, last Support is 6/16/06 at $0.0189

Chart-wise it just looks like another dump is needed..

Older

Immune Response fka IMNR (IMNR)

Followers	4	Posters	70
Posts (Today)	0	Posts (Total)	236
Created	08/17/03	Type	Free
Moderators

Company Website http://www.imnr.com/ The Immune Response Corporation (OTCBB: IMNR.OB) is an immuno-pharmaceutical company focused on developing products to treat autoimmune and infectious diseases. The Company’s lead immune-based therapeutic product candidates are NeuroVax™ for the treatment of MS and IR103 for the treatment of HIV infection. Both of these therapies are in Phase II clinical development and are designed to stimulate pathogen-specific immune responses aimed at slowing or halting the rate of disease progression. NeuroVax™, which is based on the Company’s patented T-cell receptor (TCR) peptide technology, has shown potential clinical value in the treatment of relapsing forms of MS. NeuroVax™ has been shown to stimulate strong, disease-specific cell-mediated immunity in nearly all patients treated and appears to work by enhancing levels of FOXP3+ Treg cells that are able to down-regulate the activity of pathogenic T-cells that cause MS. Increasing scientific findings have associated diminished levels of FOXP3+ Treg cell responses with the pathogenesis and progression of MS and other autoimmune diseases such as rheumatoid arthritis (RA), psoriasis and Crohn’s disease. In addition to MS, the Company has open Investigational New Drug Applications (IND) with the FDA for clinical evaluation of TCR peptide-based immune-based therapies for RA and psoriasis. IR103 is based on the Company’s patented whole-inactivated virus technology, co-invented by Dr. Jonas Salk and indicated to be safe and immunogenic in extensive clinical studies of REMUNE®, the Company’s first generation HIV product candidate. IR103 is a more potent formulation that combines its whole-inactivated antigen with a synthetic Toll-like receptor (TLR-9) agonist to create enhanced HIV-specific immune responses. The Company is currently testing IR103 in two Phase II clinical studies as a first-line treatment for drug-naïve HIV-infected individuals not yet eligible for antiretroviral therapy according to current medical guidelines. NeuroVax™ and IR103 are in clinical development by The Immune Response Corporation and are not approved by any regulatory agencies in any country at this time. Please visit The Immune Response Corporation at www.imnr.com for more information. Recent Company News: AUGUST 1, 2006 The Immune Response Corporation Receives Approval for Expansion of Phase II Trial in France for Investigative HIV Immunotherapy IR103 JULY 24, 2006 IncreMental Advantage Initiates Coverage of The Immune Response Corporation with Price Target of $0.09 Per Share, Accumulate Rating CORPORATE HEADQUARTERS The Immune Response Corporation 5931 Darwin Court Carlsbad, California 92008 760-431-7080 Telephone 760-431-8636 Fax TRANSFER AGENT American Stock Transfer 59 Maiden Lane Plaza Level New York, NY 10038 (800) 903-3727